| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/07/2009 | WO2009058300A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009057743A1 Antiallergic drink containing lactic acid bacterium |
| 05/07/2009 | WO2009057111A2 Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system |
| 05/07/2009 | WO2009056833A2 Composition |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2009017463A3 NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE |
| 05/07/2009 | WO2009007298A3 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 05/07/2009 | WO2008157179A3 N-substituted azaindoles and methods of use |
| 05/07/2009 | WO2008148573A3 Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms |
| 05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
| 05/07/2009 | US20090118361 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 05/07/2009 | US20090118311 DHFR Enzyme Inhibitors |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118274 Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 05/07/2009 | US20090118263 Novel Adenine Compound |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090118162 Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival |
| 05/07/2009 | US20090117197 Compositions and methods for ameliorating cachexia |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117144 Recombinant flu vaccines |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117131 Pharmaceutical Composition for The Treatment or Prevention of Allergic Diseases, Use Thereof, and A Method for The Treatment or Prevention of Allergic Diseases |
| 05/07/2009 | US20090117114 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/07/2009 | US20090117112 Immunomodulatory compositions and uses therefor |
| 05/07/2009 | US20090117103 M-CSF Antibody compositions Having Reduced Levels of Endotoxin |
| 05/07/2009 | US20090117083 Immunomodulatory alkaloids |
| 05/07/2009 | US20090117079 Methods and materials for treating or preventing diseases/disorders mediated by alcohol dehydrogenase |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | DE102008003054A1 Verwendungen von 2-(Piperidinyl)methyl-2,3-dihydroimidazo(1,2-c)chinazolin-5(6H)-on zum Bereitstellen einer analgetischen Wirkung, antiallergischen Wirkung und Histamin-H1-Rezeptorantagonismuswirkung Uses of 2- (piperidinyl) methyl-2,3-dihydroimidazo (1,2-c) quinazolin-5 (6H) -one for providing an analgesic effect, anti-allergic action and Histamine H1 receptor antagonism effect |
| 05/07/2009 | CA2805976A1 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | CA2703170A1 Composition |
| 05/07/2009 | CA2702320A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | CA2700917A1 Novel pyrimidine derivatives |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055305A1 External preparation comprising prostaglandin derivative |
| 05/06/2009 | EP2055303A2 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 05/06/2009 | EP2055302A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/06/2009 | EP2054443A2 Antibodies to an epitope of agr2, assays and hybridomas |
| 05/06/2009 | EP2054417A2 Fused thiophene derivatives as mek inhibitors |
| 05/06/2009 | EP2054377A1 Chemical compounds |
| 05/06/2009 | EP2054075A1 Treatment of graft-versus-host disease |
| 05/06/2009 | EP2054058A2 Inhibitors of pyruvate kinase and methods of treating disease |
| 05/06/2009 | EP1667678B1 Animal feed composition |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1420759B1 Pharmaceutical compositions for the treatment of asthma |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1274851B1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 05/06/2009 | EP0697881B2 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 05/06/2009 | CN101426916A Improved interleukin-2 muteins |
| 05/06/2009 | CN101426913A Compositions and methods of using siRNA to knockdown gene expression and to improve solid organ and cell transplantation |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426528A Methods of using antibodies against human IL-22 |
| 05/06/2009 | CN101426523A B cell-based vaccine loaded with the ligand of natural killer T cell and antigen |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/06/2009 | CN101423832A CpG motif having immunological enhancement function to porcine nucleic acid vaccine |
| 05/06/2009 | CN101423558A Eupatorium adenophorum spreng polysaccharide and preparation method and use |
| 05/06/2009 | CN101423553A Human monoclonal antibodies to dendritic cells |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101423550A Genetic engineering immunosuppressive polypeptide and preparation method and application |
| 05/06/2009 | CN101423518A Imidazole derivates and medical use thereof |
| 05/06/2009 | CN101423497A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 05/06/2009 | CN101422614A Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 05/06/2009 | CN101422612A Method for increasing crocetin water solubility |
| 05/06/2009 | CN101422600A Use of scorpion source immunoloregulation polypeptide in preparing medicine for treating multiple sclerosis disease |
| 05/06/2009 | CN101422594A Traditional Chinese medicine composition and preparation method thereof |
| 05/06/2009 | CN101422591A Capsules capable of greatly improving immunity and preparation method thereof |
| 05/06/2009 | CN101422567A Traditional Chinese medicine cosmetic body-building liquor |
| 05/06/2009 | CN101422529A Preparation method of traditional Chinese medicine preparation |
| 05/06/2009 | CN101422505A Foot-and-mouth disease vaccine and immunological stress resistance agent of other livestock and poultry and use thereof |
| 05/06/2009 | CN101422501A Use of winged euony twigs in preparing anti-IV type allergy medicine |
| 05/06/2009 | CN101422500A Immunoenhancement regulator of pig blue-ear disease vaccine and use thereof |
| 05/06/2009 | CN101422495A Comprehensive therapy method |
| 05/06/2009 | CN101422493A Preparation method and use of ginkgo-leaf extract |
| 05/06/2009 | CN101422486A Velvet antler insulin active factor extraction method |
| 05/06/2009 | CN101422474A Use of magnesium isoglycyrrhizinate preparation for vein in treating skin disease |
| 05/06/2009 | CN101422467A Immunosuppressant containing Withanolide type compound |
| 05/06/2009 | CN101422445A Preparation method and use of pidotimod effervescent tablets |
| 05/06/2009 | CN101422427A Magnesium isoglycyrrhizinate cream and preparation method and use thereof |
| 05/06/2009 | CN101422424A Mycophenolic acid medicine implantation agent and preparation method and use thereof |
| 05/06/2009 | CN100484956C Compound from catarrh mollase bacterial |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528240 Method for producing human anti-thymocyte immunoglobulins |
| 05/05/2009 | US7528224 Human Leucocyte antigen-A2 binding peptide having an amino acid sequence from a signal peptide encoded by the MUC-1 gene; immune reaction against tumor cells further increased by the simultaneous use of cytotoxic T cells directed against both peptides presented by MHC-1 molecules. |
| 05/05/2009 | US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/05/2009 | US7528148 Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7528120 phosphoric acid mono-[2-hydroxymethyl-4-(4-octyl-phenyl)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-butyl] ester; disorders mediated by lymphocytes interactions like transplant rejection, graft versus host disease, autoimmune diseases; binding affinity to Sphingosine-1-phosphate(S1P) receptors |